Ghana will in September this year begin trials for the new Malaria vaccine, Mosquirix.
Three regions, Central, Bono Ahafo and Volta Regions have been selected for the pilot programme.
Last year, Ghana together with Kenya and Malawi were selected by the World Health Organization to test the injectable vaccine. About 360 thousand children are to be vaccinated between 2018 and 2020 in Africa which records 92 percent of malaria cases worldwide.
A member of the Technical Group working on the new vaccine, Dr. K.O Antwi Adjei in an interview with Felix Cofie, said the three regions were chosen due to high malaria prevalence.
Dr. Antwi Adjei said the trial will go on till 2020 and will target children aged six months to two years.